| Chemical & Physical Properties | |
|---|---|
| CAS Number | 1416446-40-6 |
| Catalog No. | 2A-3180093 |
| Chinese Name | 3-(2-(((4-(N-(乙氧基羰基)氨基甲酰亚胺)苯基)氨基)甲基)-1-甲基-N-(吡啶-2-基)-1H-苯并[d]咪唑-5-甲酰氨基丙酸乙酯(达比加群杂质) |
| Molecular Formula | C30H33O5N7 |
| Molecular Weight | 571.64 |
| Storage Condition | 2-8°C, protect from light |
| PubChem ID | 240278418 |
| MDL Number | MFCD31380092 |
| SMILES | CCOC(=O)CCN(C(=O)c1ccc2c(c1)nc(CNc1ccc(C(=N)NC(=O)OCC)cc1)n2C)c1ccccn1 |
| InChI | InChI=1S/C30H33N7O5/c1-4-41-27(38)15-17-37(25-8-6-7-16-32-25)29(39)21-11-14-24-23(18-21)34-26(36(24)3)19-33-22-12-9-20(10-13-22)28(31)35-30(40)42-5-2/h6-14,16,18,33H,4-5,15,17,19H2,1-3H3,(H2,31,35,40) |
| InChI Key | NROPEVJSKVOJOL-UHFFFAOYSA-N |
| Transport Info | Product name: 3-(2-(((4-(N-(ethoxycarbonyl)carbaimido)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamidopropionate ethyl ester (dabigatran impurity) |
| Related Products in Analytical Standards | ||
|---|---|---|
| Topiroxostat Impurity | 2044702-36-3 | 2A-3180083 |
| Eptifibatide impurity 3/Deamidated Eptifibatide Impurity/(3R,11S,17S,20S,25aS)-20-((1H-indol-3-yl)Methyl)-17-(carboxymethyl)-11-(4-guanidinobutyl)-1,9,12,15,18,21-hexaoxodocosahydro-1H-pyrrolo[2,1-g][1,2,5,8,11,14,17,20]dithiahexaazacyclotricosine-3-carbo | 618118-95-9 | 2A-3180086 |
| Solifenacin Impurity 1 | 1353274-25-5 | 2A-3180087 |
| Solifenacin EP Impurity B | 1534326-81-2 | 2A-3180088 |
| Dabigatran Impurity 37 | 211914-96-4 | 2A-3180092 |
| Atorvastatin Impurity 36 | 1624328-52-4 | 2A-3180095 |
| Minocycline Impurity 9 | 601455-95-2 | 2A-3180099 |
| Mirabegron Impurity 17 | 1684452-84-3 | 2A-3180168 |
| Fasudil Impurity 1 HCl 2 | 166895-76-7 | 2A-3180170 |
| Lacosamide impurity 8/Lacosamide EP Impurity H/(S)-2-acetamido-N-((S)-1-(benzylamino)-3-methoxy-1-oxopropan-2-yl)-3-methoxypropanamide | 1375090-19-9 | 2A-3180175 |
| Browse all Analytical Standards products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA
EN
SDS